Clinical Trial

Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This research study is being conducted to see if coenzyme Q10 (a nutritional supplement) might help to prevent and/or alleviate symptoms and health consequences and help to improve quality of life and physical function in residents affected by the February 2023 East Palestine, Ohio train derailment. This is a pilot study that is not powered to achieve benefit but seek to examine effect size and variance to aid in power calculations for a potential future better powered study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-29.
Trial Details
NCT Number NCT06962657
Lead Sponsor University of California, San Diego
Conditions Toxicant Induced Chronic Multisymptom Illness and Associated Symptoms and Comorbidities
Enrollment 20 participants
Start Date 2026-05-15
Primary Completion 2028-10-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01